Eakin Healthcare has announced its acquisition of Belgium based Alphamédis and its sister company, Medexia, in Luxembourg.  The move reflects the ambitious international growth strategy in this sector for the Northern Ireland headquartered business, which is designed to meet the needs of the stoma and continence care community. 
 
This acquisition follows the success of Respond, Eakin Healthcare’s award-winning UK prescription and dispensing home delivery and support service. 
 
Stuart Welland, Chief Commercial Officer for Ostomy at Eakin Healthcare, commented on this latest acquisition, 
 
“Ensuring our patients’ needs are met is at the heart of everything we do. We are proud of our track record in delivering a reliable service that our customers love and trust. We have ambitious plans for international strategic growth and have worked hard to build our Northern European Infrastructure. The experienced teams at both Alphamédis in Belgium and Medexia in Luxembourg have been expertly providing a quality service to thousands of patients for many years will add great value to our team. Combined with our Eakin Healthcare Netherlands business we are very excited about our full Benelux offering and the value we feel we can bring to our customers. 
 
We warmly welcome both teams into Eakin Healthcare and are excited to use the advantage of our combined knowledge and passion for patient care to expand in these strategically significant territories.”

The acquisition takes immediate effect with no change to company names or brands. All employees of Alphamédis and Medexia will automatically transfer to Eakin Healthcare.